1-{[1-(2-amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-2-(3-cyano-phenyl)-ethaneboronic acid

This compound is a synthetic small molecule dipeptide derivative containing a boronic acid moiety. It is structurally characterized as a peptidomimetic with the formula C23H27BN4O4 and has been referenced in chemical and structural databases under the code names PPB and DB08420. The compound has not been approved for any therapeutic use, nor does it have any known clinical indications or ongoing clinical trials. Its mechanism of action, biological targets, or pharmacological activity are not described in public drug databases, suggesting it remains an experimental research molecule without established pharmaceutical application[3][6][4].

Other names

D-Phenylalanyl-N-[(1R)-2-(3-cyanophenyl)-1-(dihydroxyboryl)ethyl]-L-prolinamide(1R)-1-{[(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-2-(3-cyanophenyl)ethylboronic acid